The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated that if there is a compelling case for use of a vaccine before it is licensed, they would be prepared to authorise its emergency use or conditional approval on public health ground...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jerome Amir, Upshur, Ross E G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Personal View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832518/
https://www.ncbi.nlm.nih.gov/pubmed/33306980
http://dx.doi.org/10.1016/S1473-3099(20)30923-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832518/
https://www.ncbi.nlm.nih.gov/pubmed/33306980
http://dx.doi.org/10.1016/S1473-3099(20)30923-3

Ejemplares similares